Andrew W Roberts

42PUBLICATIONS
144CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 09, 2026
The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

|Sep 02, 2026
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

|Jul 29, 2026
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

|Apr 09, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled

|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

|Jan 10, 2025
Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genes.

Hongke Peng, Jafar S Jabbari, Luyi Tian

Pageof 7

Frequent Collaborators

15 joint publications

Xin Huang

12 joint publications

John F Seymour

8 joint publications

Andrew H Wei

8 joint publications

Constantine S Tam